Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study by Ramirez, Paula et al.
RESEARCH Open Access
Diagnostic implications of soluble triggering receptor
expressed on myeloid cells-1 in patients with acute
respiratory distress syndrome and abdominal
diseases: a preliminary observational study
Paula Ramirez
1*, Pedro Kot
1, Veronica Marti
1, Maria Dolores Gomez
2, Raquel Martinez
3, Vicente Saiz
4,
Francisco Catala
4, Juan Bonastre
1, Rosario Menendez
3
Abstract
Introduction: Patients admitted to the intensive care unit (ICU) because of acute or decompensated chronic
abdominal disease and acute respiratory failure need to have the potential infection diagnosed as well as its site
(pulmonary or abdominal). For this purpose, we measured soluble triggering receptor expression on myeloid cells-
1 (sTREM-1) in alveolar and peritoneal fluid.
Methods: Consecutive patients (n = 21) with acute or decompensated chronic abdominal disease and acute
respiratory failure were included. sTREM was measured in alveolar (A-sTREM) and peritoneal (P-sTREM) fluids.
Results: An infection was diagnosed in all patients. Nine patients had a lung infection (without abdominal
infection), 5 had an abdominal infection (without lung infection) and seven had both infections. A-sTREM was
higher in the patients with pneumonia compared to those without pneumonia (1963 ng/ml (1010-3129) vs. 862
ng/ml (333-1011); P 0.019). Patients with abdominal infection had an increase in the P-sTREM compared to patients
without abdominal infection (1941 ng/ml (1088-3370) vs. 305 ng/ml (288-459); P < 0.001). A cut-off point of 900
pg/ml of A-sTREM-1 had a sensitivity of 81% and a specificity of 80% (NPV 57%; PPV 93%, AUC 0.775) for the
diagnosis of pneumonia. In abdominal infections, a cut-off point for P-sTREM of 900 pg/ml had the best results
(sensitivity 92%; specificity 100%; NPV 90%, PPV 100%, AUC = 0.903).
Conclusions: sTREM-1 measured in alveolar and peritoneal fluids is useful in assessing pulmonary and peritoneal
infection in critical-state patients-A-sTREM having the capacity to discriminate between a pulmonary and an extra-
pulmonary infection in the context of acute respiratory failure.
Introduction
Patients with acute or decompensated chronic abdom-
inal diseases can develop acute respiratory insufficiency,
the etiology of which is difficult to identify. The diffi-
culty arises because the condition is a result of acute
respiratory failure, which is caused by an inflammatory
response that is secondary to the abdominal pathology
or that is due to nosocomial pneumonia [1,2]. In this
context, the diagnosis of an abdominal or lung infection
can be complicated by several factors: (a) the systemic
signs and symptoms of infection are non-specific, (b)
the clinical data and the radiographic findings within
the context of the patient in the intensive care unit
(ICU) do not provide high specificity for either of the
possibilities, and (c) the microbiological findings can be
altered by previous antibiotic use. Hence, the therapeu-
tic attitude, the management of the patient, and the
prognosis would depend heavily on the identification of
the focus of the infection.
The use of markers of systemic inflammation in the
diagnosis and in therapeutic decision-making is progres-
sively more valuable in clinical practice [3]. One of the
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any medium, provided the original work is properly cited.more frequent applications is in the differential diagno-
sis between the inflammatory pictures of infection ver-
sus non-infection [4]. However, the measurement of
inflammation markers in the circulation does not iden-
tify the focus of the infection [5]. Determinations of C-
reactive protein or procalcitonin (PCT) in the alveolar
fluid have been useless to diagnose infection as cyto-
kines [6-8]. Conversely, the measurement of the trigger-
ing receptor expressed on myeloid cells 1 (TREM-1) in
alveolar, pleural, sinovial, and cerebrospinal fluids has,
indeed, been demonstrated to be useful in several stu-
dies [5,9-12]. Also, an increase in TREM-1 has been
observed in peritoneal fluid following the induction of
peritonitis in an animal model [13].
Our hypothesis for this study is that the determination
of soluble TREM-1 (sTREM-1) in alveolar and perito-
neal fluids in seriously ill patients with abdominal dis-
eases and respiratory insufficiency could be useful in
identifying the existence of an infection. It is plausible
that the local increase in sTREM-1 would be higher in
the presence of infection, and this would enable us to
distinguish pulmonary or extrapulmonary infection as
the etiology of acute respiratory failure.
The objective of the present study was to investigate
the diagnostic value of sTREM in bronchoalveolar
lavage and peritoneal fluid in patients admitted to the
ICU with severe respiratory insufficiency and an abdom-
inal disease. We wished, as a secondary objective, to
compare the diagnostic value of cutoff points of sTREM
in both of these biological fluids.
Materials and methods
Design of the study
We conducted a prospective observation study of conse-
cutive cases.
Study site and subjects
The study was conducted in the ICU for a period of 18
months. The patients selected needed to fulfill the fol-
lowing criteria: (a) acute abdominal pathology, (b)
respiratory insufficiency with acute respiratory distress
syndrome (ARDS) criteria of not more than 3 days in
duration, and (c) admission to the ICU. We excluded
patients in whom it was not possible to extract a sample
of peritoneal fluid. The protocol was reviewed and
approved by the local ethics committee, and the patients
(or their relatives) provided informed consent to partici-
pation in the study. The written consent included the
permission to collect and publish (anonymously) perso-
nal data concerning the patients.
Protocol for data collection
The following data were collected: age, gender, chronic dis-
eases, vital signs, Acute Physiology Score, Acute Physiology
and Chronic Health Evaluation II (APACHE II) score [14],
Sepsis-related Organ Failure Assessment (SOFA) score
[15], presence or absence of systemic inflammatory
response syndrome [16], data on gas exchange and the
mode of mechanical ventilation, radiological assessments,
and the score on the modified Clinical Pulmonary Infection
Score (CPIS) [17]. With respect to the abdomen, data were
collected via physical examination, and the intra-abdominal
pressure was measured via vesical probe. Other data
included radiological assessments, intraoperative findings,
blood chemistry, and microbiology laboratory findings.
With respect to the lung, data were collected on the
macroscopic aspects of the respiratory secretions, the
Gram bacteria staining of mini-bronchoalveolar lavage
(mini-BAL) fluid sent to the microbiology laboratory, and
the quantitative isolations in culture.
Definitions
Diagnosis of hospital-acquired pneumonia, the pneumo-
nia associated with mechanical ventilation, or pneumo-
nia related to the health-care provision was conducted
in accordance with the criteria recommended by the
American Thoracic Society and the Infectious Diseases
Society of America [18]. The diagnosis of the abdominal
infection focus was performed in accordance with the
Centers for Disease Control and Prevention (Atlanta,
GA, USA) criteria for gastrointestinal infection and for
infections associated with surgery [19].
Collection and processing of the isolated abdominal fluid
Fine-needle aspiration puncture was performed under
echographic guidance by experienced interventional
radiologists. After vortex mixing, the sample was sepa-
rated into three aliquots: the first was stored at -70°C
until required for analysis, the second was sent for cyto-
biochemical analyses, and the third was sent to the
microbiology laboratory.
Collection and processing of the alveolar liquid
The sample of alveolar liquid was obtained using a small
(20 mL of physiologic saline) volume of bronchoalveolar
lavage (mini-BAL) [20]. After vortex mixing, the sample
was centrifuged into two phases: the supernatant was
separated and frozen at -70°C until required for ana-
lyses, and the infranatant was sent to the microbiology
laboratory. The cutoff value of mini-BAL for the diagno-
s i so fl u n gi n f e c t i o nw a s1 0
3 colony-forming units per
milliliter.
Measurement of inflammation markers
Serum PCT was measured with time-resolved amplified
cryptate emission (TRACE) technology in a Kryptor
analyzer (Brahms Diagnostic a ,B e r l i n ,G e r m a n y ) .T h e
sTREM-1 was determined by immunoassay with a
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IgG1 type raised against TREM-1 (R&D Systems, Inc.,
M i n n e a p o l i s ,M N ,U S A ) .T h ea s s a yw a sp e r f o r m e di n
accordance with the instructions of the manufacturer.
Statistical analyses
All statistical analyses were performed with SPSS ver-
sion 15 software (SPSS, Inc., Chicago, IL, USA). The c
2
test was used for categorical variables, and the Student t
or Mann-Whitney test was used for continuous vari-
ables. The values for PCT and sTREM-1 were expressed
as medians with the interquartile ranges (25% to 75%)
in parenthesis. Diagnostic capacities of alveolar sTREM-
1, peritoneal sTREM-1, and the alveolar-to-peritoneal
sTREM-1 ratios were evaluated with the receiver operat-
ing characteristic curves. Sensitivity and specificity as
well as positive (PPV) and negative (NPV) predictive
values were calculated.
Results
Twenty-two patients fulfilled the inclusion criteria. One
patient was censored because of our inability to obtain
abdominal fluid. The mean age (± standard deviation)
was 48.2 ± 16.7 years, and 57% (n = 12) were males. Ele-
ven patients (52%) had a chronic abdominal disease,
seven patients (33%) had hepatic cirrhosis, and one
patient each had intestinal graft-versus-host disease,
Budd-Chiari syndrome, cystic fibrosis, and intestinal
lymphoma. The acute abdominal diseases diagnosed
were spontaneous bacterial peritonitis in 29% of cases,
acute enteritis in 19%, acute pancreatitis in 14%, diges-
tive tract hemorrhage in 14%, and acute hepatitis in
10%, and 1 case each (5%) had cholecystitis, hepatic
abscess, and intestinal subocclusion. The mean score on
the APACHE II scale on the day of admission to the
ICU was 18.6 ± 5.8 points. The intra-ICU mortality was
76.2%. Table 1 shows the individual characteristics of
the patients in the study.
General characteristics upon entry into the study
The mean stay in the ICU was 4.04 ± 2.3 days, and the
mean duration of ventilation was 2.85 ± 1.2 days. The
mean body temperature was 38.3 ± 1°C, the leukocytes
were 10,176 ± 6,736 cells/mL (median 11,600, range
4,600 to 13,650), and the plasma PCT was 17.77 ± 25.42
ng/mL (median 7.9, range 1.84 to 18.96). The mean
SOFA score was 12.8 ± 3.4 points. All of the cases
required wide-spectrum antibiotic treatment and inva-
sive mechanical ventilation with an elevated fraction of
inspired oxygen (FiO2 =0 . 7±0 . 2a n dp o s i t i v ee n d -
expiratory pressure = 9 ± 2.5 mm Hg). Fourteen
patients (66.7%) were in shock with a need for vasoac-
tive drugs, and four (19%) underwent the technique of
continuous renal replacement therapy (Table 2).
Table 1 Baseline characteristics of the patients
Case Chronic abdominal pathology Other complaints Admission to hospital APACHE II score Exitus
1 No No Hepatic lesions 13 Yes
3 Intestinal GVHD Acute myeloid leukemia Sepsis 15 Yes
4 Hepatic cirrhosis No Gastrointestinal bleeding 24 Yes
5 No Acute lymphatic leukemia Enteritis 19
6 No No Acute pancreatitis 18 No
7 Hepatic cirrhosis AIDS Gastrointestinal bleeding 21 Yes
8 Hepatic cirrhosis No Gastrointestinal bleeding 20 No
9 Budd-Chiari syndrome No Respiratory failure 10 Yes
10 No No Acute pancreatitis 20 Yes
11 No No Intestinal subocclusion 25 No
12 No Alcoholism Acute pancreatitis 23 Yes
13 No AIDS Acute hepatitis 12 Yes
14 No No Paralyzed ileum Yes
15 Hepatic cirrhosis AIDS Hydropic decompensation 29 Yes
16 No Acute myeloid leukemia Sepsis 19 Yes
17 Cystic fibrosis Hepato-bipulmonary transplant Hepato-bipulmonary transplant 9 Yes
18 Hepatic cirrhosis No Cholecystitis 11 No
19 Intestinal lymphoma No Acute hepatitis 14 No
20 No No Acute pancreatitis 25 Yes
21 Hepatic cirrhosis No Gastrointestinal bleeding 19 Yes
22 Hepatic cirrhosis No Hydropic decompensation 26 Yes
Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. APACHE II, Acute Physiology and Chronic Health Evaluation II;
GVHD, graft-versus-host disease.
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study
The mean score on the CPIS was 5.4 ± 2.4 points (med-
ian 6, range 3 to 7). The mean parameters of gas
exchange were pH = 7.33 ± 0.11, partial pressure of oxy-
gen (pO2) = 42.2 ± 12.7 mm Hg, partial pressure of car-
bon dioxide (pCO2) = 82.9 ± 28.3 mm Hg, bicarbonate
= 19.9 ± 3.3 mmol/L, and arterial partial pressure of
oxygen (PaO2)/FiO2 ratio = 122.7 ± 43.4. Radiological
findings were 8 localized condensations (38%), 11 diffuse
interstitial infiltrate (52.5%), and 2 pleural effusions
(9.5%). Sixteen patients (76%) had a definitive diagnosis
of pulmonary infection: 7 of them also had an abdom-
inal infection (in 5 of these, the infection was systemic
and caused by the same microorganism). The median
alveolar sTREM-1 was 1,437 (range 656 to 2,512) pg/mL
(Table 3).
Abdominal characteristics on the day of inclusion in the
study
The mean level of glucose in the peritoneal fluid was
157.64 ± 77 mg/dL (median 161, range 104 to 330), and
the mean of neutrophils was 406.5 ± 1,108 cells/mm
3
(median 51, range 10 to 249). The mean intra-abdominal
pressure was 15.06 mm Hg. The diagnosis of abdominal
infection was established in 12 patients (57%); in 7 of
these patients, the diagnosis of lung infection was estab-
lished as well. The median value of s-TREM in peritoneal
fluid was 933 (range 305 to 2,560) pg/mL (Table 4).
Capacities of A-sTREM and P-sTREM to diagnose lung and
abdominal infections, respectively
Nine patients had lung infection (without abdominal
infection), 5 had abdominal infection (without lung
infection), and 7 had both infections. The patients with
lung infection had a higher CPIS and a greater alveolar
sTREM-1 (P = 0.019 and P = 0.019, respectively) com-
pared with those without lung infection. The patients
with abdominal infection had a lower CPIS and
increased plasma PCT and peritoneal sTREM (P =
0.002, P =0 . 0 1 8 ,P < 0.001, respectively) compared with
those without abdominal infection (Tables 5 and 6).
The best cutoff point of alveolar sTREM for the diagno-
sis of lung infection was 900 pg/mL (sensitivity 81%, speci-
ficity 80%, PPV 93%, NPV 57%, and area under the curve
[AUC] 0.775). In abdominal infection, the best cutoff point
of peritoneal sTREM was 900 pg/mL (sensitivity 92%, spe-
cificity 100%, PPV 100%, NPV 90%, and AUC 0.903).
Table 2 Characteristics of the patients upon inclusion in the study
Case SOFA
score
Antibiotics Vasoactive
drugs
CRRT Procalcitonin, ng/
mL
Temperature, °
C
Leukocytes,/
mm
3
Final diagnosis
1 11 Yes Yes No 96.46 39.0 9,800 Systemic infection
a
3 14 Yes Yes No 40.9 37.0 1,100 Systemic infection
b
4 12 Yes No No 1.28 36.4 7,600 VAP
5 16 Yes No No 18.62 40.0 0 Enteritis + VAP
6 12 Yes Yes Yes 15.0 38.6 21,200 VAP + infected
pancreatitis
7 13 Yes Yes No 3,054 38.8 11,700 Nosocomial pneumonia
8 16 Yes Yes No 3.5 39.0 2,900 VAP
9 14 Yes Yes No 10.38 28.0 20,400 HAP
10 15 Yes Yes Yes 50.0 38.0 11,600 VAP + infected
pancreatitis
11 9 Yes Yes No 4.53 37.8 14,100 VAP
12 11 Yes No Yes 13.0 38.2 7,600 Infected pancreatitis
13 11 Yes No No 0.833 38.0 12,700 SBP
14 11 Yes Yes No 68.65 40.0 13,200 Enteritis
15 21 Yes Yes No 19.3 37.6 12,400 SBP
16 16 Yes Yes No 7.9 39.3 200 Enteritis
17 6 Yes No No 0.784 36.0 6,600 Systemic infection
c
18 7 Yes No No 0.49 38.8 11,900 HAP
19 16 Yes Yes No 0.90 37.0 6,100 HAP
20 12 Yes Yes Yes 10.74 38.8 23,200 VAP
21 12 Yes No No 2.41 38.7 3,100 VAP
22 14 Yes Yes No 4.44 38.0 16,300 VAP + SBP
Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. ‘Systemic infection’ indicates that the same infection affected both
the abdomen and lungs:
aseptic thrombophlebitis of the portal vein by Salmonella tiphy with hematogenous pneumonia;
bcitomegaloviruses colitis and
pneumonia;
csystemic infection (lung + abdominal) by Aspergillus fumigates. CRRT, continuous renal replacement therapy; HAP, hospital-acquired pneumonia; SBP,
spontaneous bacterial peritonitis; SOFA, Sepsis-related Organ Failure Assessment; VAP, ventilator-associated pneumonia.
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ratio to discriminate the infection focus
Nine patients had lung infection (without abdominal
infection), 5 had abdominal infection (without lung
infection), and 7 had both infections. All patients with
just lung infection had an alveolar-to-peritoneal sTREM
ratio of greater than 1, and all patients with just abdom-
inal infection had an alveolar-to-peritoneal sTREM ratio
of less than 1. However, patients with both infections
had a huge variability, preempting any effective clinical
application of the ratio.
Discussion
The results of our study demonstrate the usefulness
(high predictive value) of measuring sTREM-1 in alveo-
lar and peritoneal fluids in the diagnosis of pulmonary
or abdominal infection (or both) in the context of
ARDS. A-sTREM-1 was able to identify pneumonia as a
pathogenic factor for ARDS. The relationships between
the alveolar and peritoneal sTREM-1 values identified
the focus of the infection.
The application of the sTREM-1 measurement for
diagnosing pulmonary infections has had conflicting
results. In the original study by Gibot and colleagues [5]
and in subsequent studies [10], the measurement of
alveolar sTREM achieved good results. Gibot and collea-
gues [5] found an area under the receiver operating
characteristic curve for alveolar sTREM-1 of 0.93 (95%
confidence interval 0.92 to 0.95) in patients with com-
munity-acquired pneumonia or ventilator-associated
pneumonia (VAP). In their study, Determann and col-
leagues [10] established a cutoff of 200 pg/mL of alveo-
lar sTREM-1 with a sensibility of 75% and a specificity
of 84% in the diagnosis of VAP. More recent studies by
Anand and colleagues [21] and by others [22] did not
reach the same conclusions. The discordance in the
findings could be due to differences in the techniques
for alveolar sample acquisition, in the method of mea-
surement of sTREM-1, or i nt h et y p eo fp a t i e n t s
included in the study. Anand and colleagues [21] segre-
gated their patient population as those without VAP (n
= 21), with definite VAP (n = 19), with indefinite VAP
Table 3 Respiratory characteristics of the patients
Case Days under invasive
MV
PaO2/
FiO2
Chest x-ray CPIS Alveolar
microbiology
Alveolar sTREM-1,
pg/mL
Lung
infection
Type of
infection
1 3 167 Diffused interstitial 3 Salmonella tiphy 1,437 Yes HAP
3 1 111 Diffused interstitial 3 CMV 434 Yes HAP
4 2 83 Diffused interstitial 6 Acinetobacter
baumannii
2,475 Yes HAP
5 7 69 LRL condensation 8 A. baumannii 430 Yes VAP
6 6 180 LLL condensation 6 A. baumannii 2,166 Yes VAP
7 4 80 Bilateral infiltrate 6 Escherichia coli 1,755 Yes HAP
8 2 172 Diffused interstitial 5 Staphylococcus
aureus
3,322 Yes HAP
9 2 111 Pulmonary
condensation, R
7 Aspergillus fumigatus 3,399 Yes HAP
10 3 108 Bilateral infiltrate 6 Haemophilus
influenzae
3,758 Yes VAP
11 4 190 LRL condensation 6 E. coli 1,167 Yes HAP
12 2 93 Bilateral infiltrate 1 Negative 862 No
13 3 132 Pleural effusion, R 2 Negative 229 No
14 1 160 Diffused interstitial 4 Negative 883 No
15 1 91 Diffused interstitial 4 Candida albicans 1,139 No
16 1 64 Diffused interstitial 4 Negative 437 No
17 1 195 Diffused interstitial 3 A. fumigatus 2,382 Yes HAP
18 1 125 Bilateral pleural
effusion
9 Pseudomonas
aeruginosa
175 Yes HAP
19 2 130 Bi-basal condensation 5 A. fumigatus 2,550 Yes HAP
20 6 58 Pulmonary
condensation, L
8 P. aeruginosa 958 Yes VAP
21 6 95 LRL condensation 7 A. baumannii 450 Yes VAP
22 2 163 LRL condensation 8 S. aureus 3,986 Yes HAP
Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. CPIS, Clinical Pulmonary Infection Score; HAP, hospital-acquired
pneumonia; L, left; LLL, lower left lobe; LRL, lower right lobe; MV, mechanical ventilation; PaO2/FiO2, arterial partial pressure of oxygen/fraction of inspired
oxygen; R, right; VAP, ventilator-associated pneumonia.
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lyzed only the first two of these groups. Although the
group with VAP showed higher levels of sTREM-1
(171.9 ± 158.7 pg/mL) than the group without VAP
(96.7 ± 76.2 pg/mL), this difference did not reach statis-
tical significance (P = 0.06) [21]. In our study, the
patients with lung infection had a higher level of alveo-
lar sTREM than the patients without lung infection
(mean 1,963 pg/mL, interquartile range 1,010 to 3,129
versus 862 pg/mL, interquartile range 333 to 1,011; P =
0.019). Of note is that the values of sTREM-1 observed
in our study do not compare with those observed by
Anand and colleagues [21], who used the same analyti-
cal method as we did (that is, enzyme-linked immu-
noabsorbent assay). The differences could be due to the
extreme status of our patient population (SOFA score
12.8 ± 3.4); the study of Anand and colleagues does not
report SOFA score. With a cutoff point of 900 pg/mL,
the specificity is high and the PPV reaches 100%.
The measurement of sTREM-1 in peritoneal fluid as a
diagnostic method has been less studied. It has been
tested in an animal model in which the induction of
Table 4 Abdominal characteristics of the patients
Case IAP,
mm Hg
Neutrophils in
peritoneal fluid, mm
3
Glucose in peritoneal
fluid, mg/dL
Peritoneal fluid
microbiology
Peritoneal sTREM-
1, pg/mL
Abdominal
infection
Type of
infection
1 130 Salmonella tiphy 305 Yes Hepatic
abscesses
3 15 1,670 228 Polymicrobial 2,871 Yes Colitis CMV
4 18 0 179 Negative 482 No
51 8 Acinetobacter
baumannii
935 Yes Enteritis
6 103 154 A. baumannii 1,242 Yes Pancreatic
infection
7 18 10 238 Negative 445 No
8 10 128 Negative 288 No
9 13 30 45 Negative 459 No
10 22 12,700 Negative 3,474 Yes Pancreatic
infection
11 16 248 Negative 227 No
12 15 0 127 Enterococcus faecalis 3,267 Yes Pancreatic
infection
13 11 544 93 Negative 1,423 Yes SBP
14 11 Negative 2,250 Yes Enteritis
a
15 7 462 34 Negative 1,633 Yes SBP
16 17 0 186 Negative 933 Yes Enteritis
b
17 Candida krusei,
Enterococcus faecium
3,634 Yes Enteritis
c
18 11 51 169 Negative 305 No
19 25 249 108 Negative 301 No
20 14 10 Negative 854 No
21 14 148 285 Negative 174 No
22 12 4,365 30 Escherichia coli 4,406 Yes SBP
Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid.
aDiagnosed from surgical findings;
bdiagnosed from necropsy
findings;
cclinical and microbiological diagnoses. CMV, cytomegalovirus; IAP, intra-abdominal pressure; SBP, spontaneous bacterial peritonitis; sTREM-1, soluble
triggering receptor expressed on myeloid cells 1.
Table 5 Identification of pulmonary (alveolar) and abdominal (peritoneal) infection
Lung infection Abdominal infection
Yes No P value Yes No P value
CPIS 6.5 (3.7-7.7) 4 (1.5-4.5) 0.019 3.5 (3.5-5.7) 7 (6-8) 0.002
Serum PCT, ng/mL 4.5 (1.9-16.8) 13 (7.9-19.3) 0.409 16.8 (6.2-45.4) 3.05 (6-8) 0.018
A-sTREM, pg/mL 1,963 (1,010-3,129 862 (333-1,011) 0.019 1,011 (435-2,274) 1,760 (1,167-2,550) 0.177
P-sTREM, pg/mL 470 (303-2056) 1,633 (1,423-2,250) 0.117 1,941 (1,088-3,370) 305 (288-459) <0.001
A-sTREM, alveolar soluble triggering receptor expressed on myeloid cells; CPIS, Clinical Pulmonary Infection Score; PCT, procalcitonin; P-sTREM, peritoneal soluble
triggering receptor expressed on myeloid cells.
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peritoneal fluid [13]. Recently, Determann and collea-
gues [23] analyzed the capacity of peritoneal sTREM-1
to diagnose the persistence of secondary peritonitis
post-surgery. The authors, in a sequential study of
sTREM-1, observed that the patients with persistent
infection at 48 hours post-surgery had a significantly
h i g h e rm e d i a ns T R E M - 1( 3 1 9v e r s u s8 5p g / m L ;P =
0.001). We confirmed that patients with abdominal
infection had elevated levels of peritoneal sTREM-1 of
1,941 pg/mL (interquartile range 1,088 to 3,370) versus
305 pg/mL (interquartile range 288 to 459) (P <0 . 0 0 1 ) .
Furthermore, with a cutoff point of at least 900 pg/mL,
the diagnostic value showed high sensitivity (92%), spe-
cificity (100%), PPV (100%), and NPV (90%).
As expected, body temperature and plasma leukocyte
counts were ineffective in identifying the infection focus.
Elevated levels of plasma PCT were associated with
abdominal infection, whereas 60% of the patients with
pulmonary infection had a serum PCT level of less than
2.5 ng/mL.
In our study, we used the measurement of sTREM-1
in alveolar and peritoneal fluids to discriminate the
etiology of acute respiratory failure. However, the rela-
tively high percentage of patients who have a systemic
infection coexisting with abdominal and pulmonary
infections complicates this objective. All patients with
lung infection alone had an alveolar-to-peritoneal
sTREM ratio of greater than 1, and all patients with
abdominal infection alone had an alveolar-to-peritoneal
sTREM ratio of less than 1. However, patients with both
infections had a huge variability, preempting an effective
clinical application of the ratio.
The principal limitation of our study is the small sam-
ple size. This important limitation, which precludes the
generalization of the findings, is partially balanced by
the novelty of the two aspects of the study design (that
is, the application of sTREM-1 to the diagnosis of
abdominal infection and the concomitant determination
of the sTREM-1 in two different sites to establish the
infection focus). Our results need to be corroborated in
a study with a larger sample size. The second limitation
is the heterogeneity of our cohort. We included neutro-
penic patients in whom the usefulness of sTREM-1 has
not been established. However, in our neutropenic
patients, peritoneal and alveolar sTREM-1 levels showed
results similar to those in non-neutropenic patients.
Although the diagnosis of infection had been performed
in accordance with established criteria, the microbiology
results could have been affected by the generalized use
of broad-spectrum antibiotics.
Conclusions
The results of our study show that the measurement of
sTREM-1 is useful in the diagnosis of pulmonary infec-
tion and of abdominal infection in the context of severe
acute respiratory failure. Further studies with a larger
sample sizes are fully warranted to confirm the useful-
ness of sTREM-1 found in this preliminary study. More-
over, on the basis of our findings, the accuracy of this
marker in neutropenic patients should be explored.
Key messages
￿ Alveolar soluble triggering receptor expressed on
myeloid cells 1 (sTREM-1) is useful in diagnosing
lung infections in the context of acute respiratory
distress syndrome.
￿ Peritoneal sTREM-1 is capable of identifying an
abdominal infection, including those developed in
the setting of a chronic abdominal disease as sponta-
neous bacterial peritonitis in patients with hepatic
cirrhosis.
￿ sTREM-1 seems to be the ideal biomarker to iden-
tify the site of infection in critical care patients when
measured in fluids coming from the suspected
tissues.
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